Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 13.28 is 103% above its 5-year average of 6.53, near the high end of its 5-year range (0.16–13.28).
As of the fiscal period ended Wednesday, December 31, 2025. 19.21% above its 12-month average of 11.14.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
13.28
EARNINGS PER SHARE (EPS) AVG TTM
11.14
EARNINGS PER SHARE (EPS) AVG 3Y
8.54
EARNINGS PER SHARE (EPS) AVG 5Y
6.53
EARNINGS PER SHARE (EPS) AVG 10Y
5.40
EARNINGS PER SHARE (EPS) AVG 15Y
6.33
EARNINGS PER SHARE (EPS) AVG 20Y
6.72
CURRENT VS TTM AVG
+19.21%
CURRENT VS 3Y AVG
+55.59%
CURRENT VS 5Y AVG
+103.37%
CURRENT VS 10Y AVG
+146.01%
CURRENT VS 15Y AVG
+109.84%
CURRENT VS 20Y AVG
+97.70%
AstraZeneca PLC
Market Cap
$132.81B
Earnings Per Share (EPS)
13.28
TTM Avg
11.14
3Y Avg
8.54
5Y Avg
6.53
Market Cap
$135.55B
Earnings Per Share (EPS)
5.63
TTM Avg
5.20
3Y Avg
6.66
5Y Avg
6.73
Market Cap
$136.45B
Earnings Per Share (EPS)
2.27
TTM Avg
2.53
3Y Avg
3.71
5Y Avg
4.39
Market Cap
$128.91B
Earnings Per Share (EPS)
8.64
TTM Avg
8.18
3Y Avg
7.73
5Y Avg
6.75
Market Cap
$128.26B
Earnings Per Share (EPS)
3.56
TTM Avg
-0.48
3Y Avg
1.47
5Y Avg
0.84
Market Cap
$125.83B
Earnings Per Share (EPS)
8.79
TTM Avg
7.27
3Y Avg
5.84
5Y Avg
5.20
Market Cap
$122.58B
Earnings Per Share (EPS)
16.86
TTM Avg
6.69
3Y Avg
10.10
5Y Avg
9.99
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $132.81B | 13.28 | 11.14 | 8.54 | 6.53 |
| Danaher Corporation (DHR)vs › | $135.55B | 5.63 | 5.20 | 6.66 | 6.73 |
| CVS Health Corp. (CVS)vs › | $136.45B | 2.27 | 2.53 | 3.71 | 4.39 |
| Stryker Corporation (SYK)vs › | $128.91B | 8.64 | 8.18 | 7.73 | 6.75 |
| Bristol-Myers Squibb Company (BMY)vs › | $128.26B | 3.56 | -0.48 | 1.47 | 0.84 |
| Intuitive Surgical, Inc. (ISRG)vs › | $125.83B | 8.79 | 7.27 | 5.84 | 5.20 |
| Pfizer Inc. (PFE)vs › | $141.19B | 1.31 | 1.39 | 2.19 | 2.39 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $122.58B | 16.86 | 6.69 | 10.10 | 9.99 |
| Medtronic plc (MDT)vs › | $108.82B | 3.73 | 3.69 | 3.25 | 3.23 |
| GSK plc (GSK)vs › | $105.18B | 4.52 | 4.58 | 5.32 | 4.82 |
Trailing EPS (TTM)
$13.28
Forward EPS (Est.)
$10.24
P/E Ratio
12.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 13.20 |
| 2024-12-31 | 9.08 |
| 2023-12-31 | 7.62 |
| 2022-12-31 | 4.24 |
| 2021-12-31 | 0.16 |
| 2020-12-31 | 4.88 |
| 2019-12-31 | 2.06 |
| 2018-12-31 | 3.40 |
| 2017-12-31 | 4.74 |
| 2016-12-31 | 5.54 |
| 2015-12-31 | 4.46 |
| 2014-12-31 | 1.96 |
| 2013-12-31 | 4.08 |
| 2012-12-31 | 9.98 |
| 2011-12-31 | 14.66 |
| 2010-12-31 | 11.20 |
| 2009-12-31 | 10.38 |
| 2008-12-31 | 8.40 |
| 2007-12-31 | 7.48 |
| 2006-12-31 | 7.72 |
| 2005-12-31 | 5.82 |
| 2004-12-31 | 436.00 |
| 2003-12-31 | 356.00 |
| 2002-12-31 | 3.28 |
| 2001-12-31 | 3.30 |
| 2000-12-31 | 2.86 |
| 1999-12-31 | 1.28 |
| 1998-12-31 | 2.94 |
| 1997-12-31 | 2.54 |
| 1996-12-31 | 2.32 |
